Low dose aspirin safely reduced thrombosis in polycythaemia veraBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7444.0-f (Published 08 April 2004) Cite this as: BMJ 2004;328:0-f
Question Is low dose aspirin safe and effective for the prevention of thrombotic complications in patients with polycythaemia vera?
Synopsis Polycythaemia vera is associated with increased blood viscosity, which in turn leads to thrombotic complications. A previous study with high dose aspirin (900 mg/day) was unsuccessful because of a high risk of gastrointestinal bleeding. In this randomised controlled (double blinded) study, 518 patients with polycythaemia, no contraindication to aspirin, and no other indication for antithrombotic therapy were randomised (allocation concealed) to aspirin …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial